Company Snapshot
- Ticker
- DVA
- Name
- DVA
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 8746301250.000000
- Volume
- 775,882
- Avg Volume (3M)
- 846,361
Interactive chart with SMA overlays and intraday breadth.
Plot valuation, momentum, or volume trends.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in Read more
Curated headlines from premium sources.
California Public Employees Retirement System decreased its position in shares of DaVita Inc. (NYSE: DVA) by 22.9% in the undefined quarter, according to the c…
Appointments of Chief People Officer and Chief Strategy Officer underscore commitment to innovation and people-first approach DENVER , Dec. 11, 2025 /PRNewswir…
DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems from its dominant US dialysis clinic …
Edgestream Partners L.P. purchased a new stake in shares of DaVita Inc. (NYSE: DVA) during the second quarter, according to its most recent disclosure with the…
Hsbc Holdings PLC lowered its holdings in DaVita Inc. (NYSE: DVA) by 4.1% in the second quarter, according to its most recent 13F filing with the Securities an…
Boston Partners reduced its position in shares of DaVita Inc. (NYSE: DVA) by 13.3% in the undefined quarter, according to the company in its most recent filing…